Herantis Pharma Oyj
HRTIS | FN
Overview
Corporate Details
- ISIN(s):
- FI4000087861
- LEI:
- 743700W4CQVYAT3WKK38
- Country:
- Finland
- Address:
- Bertel Jungin Aukio 1, FI-02600 ESPOO
- Website:
- N/A
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
Herantis Pharma Oyj develops treatments for neurodegenerative diseases like Parkinson's. Their research focuses on regenerative medicine and disease modification.
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| No filings match the current criteria. | ||||
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
Cyclezyme AB | Sweden | CYCLE | |
|
Cyxone AB | Sweden | CYXO | |
|
DBV Technologies | France | DBV | |
|
DEINOVE | France | ALDEI | |
|
Deutsche Biotech Innovativ AG | Germany | DBI | |
|
Devyser Diagnostics | Sweden | DVYSR | |
/other/Diamyd_Medical_AB_publ-logo.png?Expires=1749824290&Signature=dm~i2TKpontJYs7NhgumLAkYzSQZ4s5Ad8uv0YV9I9CpCh~NiBK9PNjK7UbmEW6iPTa7~fEV2ekmjOO0DPbje7eL6Haq1CYyTSI8WskDNpj0MubG2kqV2NdJTRSzye5ULcPCftoEwDH42dJo~W6~DoBu9O71Zzxyh5V8vNV5SAV12eMRaUuLWgIi4G0tEhBoAdQqzzd3NRI9RSIvBrg6mognKiJrhCw5CPshdp0K8cVhznAIfWan8kDk7qxwxgYQ-7Nh2T16K75bkaAr8HjOZPPlNf8X2KjzLkfEdvqMIX9b2MPaqfJ8CKxNKwv0nK7lhsu~RiRZmYYtBbJIDiktaw__&Key-Pair-Id=K6QMJA61RGOXQ){kind=logo}
|
Diamyd Medical AB (publ) | Sweden | DMYD | |
|
Diasorin | Italy | DIA | |
| DNA Group (T.R.) Ltd. | Israel | DNA | ||
|
Double Bond Pharmaceutical International AB | Sweden | DBP B |